NCT00991744: Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) |
|
|
| Suspended | 3 | 100 | Europe, RoW | Liposomal cytarabine, Cytarbine, Ara-C, Cytosar-U, Cytosine arabinoside, Precortalon, Di-Adreson F, Intrathecal triple, DepoCyte, DepoCyt, Di-Adreson-F, Cytarabine | Nordic Society for Pediatric Hematology and Oncology, Oulu University Hospital | Acute Lymphoblastic Leukemia | 12/18 | 12/18 | | |
NCT03117751: Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma |
|
|
| Active, not recruiting | 2/3 | 790 | US, RoW | Prednisone, Prednisolone, Deltasone, Meticorten, Orasone®, Liquid Pred, Pediapred®, Sterapred®, Vincristine, Vincristine sulfate, Oncovin®, VCR, LCR, Daunorubicin, Daunomycin, rubidomycin, Cerubidine®, Pegaspargase, PEG-asparaginase, PEGLA, PEG-L-asparaginase, polyethylene glycol-L-asparaginase, Oncaspar®, Erwinase®, Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi, Erwinaze^TM, Crisantaspase, Cyclophosphamide, Cytoxan®, Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Mercaptopurine, 6-MP, Purinethol®, Purixan^TM, 6-mercaptopurine, Dasatinib, Sprycel®, Methotrexate, MTX, amethopterin, Trexall®, Blinatumomab, Blincyto®, Ruxolitinib, Jakafi®, Bortezomib, Velcade®, Dexamethasone, Decadron®, Hexadrol®, Dexone®, Dexameth®, Doxorubicin, Adriamycin®, Etoposide, Etoposide Phosphate, VePesid®, Etopophos®, VP-16, Clofarabine, Clolar®, Vorinostat, Zolinza®, Suberoylanilide Hydroxamic Acid, SAHA, Idarubicin, Idarubicin HCl, 4-Demethoxydaunorubicin, 4-DMD, DMDR, Idamycin PFS®, Nelarabine, Arranon®, Atriance®, Compound 506U78, Thioguanine, 6-thioguanine, Tioguanine, 2-amino-1,7-dihydro-6H-purine-6-thione, WR-1141, Tabloid®, Lanvis®, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, Rylaze™, Recombinant Erwinia, Calaspargase Pegol, ASPARLAS | St. Jude Children's Research Hospital, Incyte Corporation, Amgen, Servier | Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma | 09/26 | 03/28 | | |